Does REVLIMID Cause Plasma cell myeloma? 632 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 632 reports of Plasma cell myeloma have been filed in association with REVLIMID. This represents 7.1% of all adverse event reports for REVLIMID.
632
Reports of Plasma cell myeloma with REVLIMID
7.1%
of all REVLIMID reports
241
Deaths
184
Hospitalizations
How Dangerous Is Plasma cell myeloma From REVLIMID?
Of the 632 reports, 241 (38.1%) resulted in death, 184 (29.1%) required hospitalization, and 24 (3.8%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVLIMID. However, 632 reports have been filed with the FAERS database.
What Other Side Effects Does REVLIMID Cause?
Pneumonia (652)
Death (565)
Diarrhoea (508)
Thrombosis (484)
Fatigue (448)
Platelet count decreased (362)
Full blood count decreased (352)
Deep vein thrombosis (332)
Pancytopenia (319)
Rash (310)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which REVLIMID Alternatives Have Lower Plasma cell myeloma Risk?
REVLIMID vs REVOLADE
REVLIMID vs REVUMENIB
REVLIMID vs REYATAZ
REVLIMID vs REZAFUNGIN
REVLIMID vs RIBASPHERE